Third, rescue experiments involving P3H4 overexpression combined with glycolysis inhibitors or PI3K/AKT pathway blockers would provide more definitive evidence of the functional relationship between P3H4 and metabolic reprogramming in HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.